Aprepitant Cap 2 x 80 mg and 1 x 125 mg: Supply issue resolved

Merk Sharpe and Dohme have advised that there is a supply issue with their aprepitant cap (2 x 80 and 1 x 125mg) tri-packs (pharmacode 2244098).

15 July 2022: Supply issue resolved

Affected product

The Emmend Tri-Pack (aprepitant Cap 2 x 80 mg and 1 x 125 mg) was affected by this issue. 

Schedule listing for aprepitant(external link)

Expected resupply date

We are advised that full aprepitant is available again. Please contact us if you experience any issues.

All parties are aware of the critical nature of this pharmaceutical. We are working with the supplier to reduce the likelihood of future supply issues for aprepitant.

Who to contact

If you have questions about the availability of this medicine, contact MSD New Zealand(external link)

If you have questions about the funding of this medicine, email enquiry@pharmac.govt.nz

When emailing us, please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.